SAFETYLIT WEEKLY UPDATE

We compile citations and summaries of about 400 new articles every week.
RSS Feed

HELP: Tutorials | FAQ
CONTACT US: Contact info

Search Results

Journal Article

Citation

Del Vecchio G, Spahn V, Stein C. ACS Chem. Neurosci. 2017; 8(8): 1638-1640.

Affiliation

Department of Anesthesiology and Critical Care Medicine, Charité- Campus Benjamin Franklin , Hindenburgdamm 30, Berlin 12203, Germany.

Copyright

(Copyright © 2017, American Chemical Society)

DOI

10.1021/acschemneuro.7b00195

PMID

28603962

Abstract

Conventional opioids mediate analgesia as well as severe adverse effects via G-protein coupled opioid receptors (OR) in both inflamed (peripheral injured tissue) and healthy (brain, intestinal wall) environments. To exclude side effects, OR activation can be selectively achieved in damaged tissue by lowering the pKa of an opioid ligand to the acidic pH of inflammation. As a result, protonation of the ligand and consequent OR binding and activation of G-proteins is pH- and injury-specific. A novel compound (NFEPP) demonstrates the feasibility of this approach and displays blockade of pain transmission only at the peripheral site of injury, but with lack of central and gastrointestinal adverse effects. These findings suggest disease-specific receptor activation as a new strategy in drug design.


Language: en

Keywords

Opioids; analgesia; inflammation; injury; opioid receptor

NEW SEARCH


All SafetyLit records are available for automatic download to Zotero & Mendeley
Print